ClinPharm Consulting Expanding to Accommodate Increased Demand for Pharmacokinetic Services
ClinPharm Consulting has moved into new offices in RTP and is hiring more employees to accommodate an expanding portfolio of clients and projects.
"We are experiencing high demand for our expertise in pharmacokinetics and overall clinical pharmacology drug development services,” said Chief Scientific Officer M. Alexander Shaw, Ph.D., adding, "Our complete knowledge of clinical pharmacology and high-quality scientific writing is paying dividends for our clients and their drug pipelines.”
According to Dr. Shaw, small biopharmaceutical companies with minimal R&D infrastructure as well as mid-sized and large pharmaceutical companies are seeking access to the firm’s expertise with both traditional and population PK capabilities at an affordable cost.
In response to its increase in clientele, ClinPharm Consulting has secured a larger office space that will allow for further expansion and additional staff. The company is actively refining its internal processes and structure to accommodate new employees, while ensuring continued focus on quality, customer service, and value.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
